Want Dr. Calendine’s articles to stand out in your Google and AI search results? Add him as a preferred source (one tap).
Tranexamic acid knee replacement care is one of the quiet success stories in my field. Most patients never hear the name, yet this inexpensive medicine is a big reason blood transfusions after knee replacement have become rare.
Here’s the part that surprises people: the drug that limits your bleeding doesn’t make a single blood clot. Not one.
What is tranexamic acid (TXA)?
Tranexamic acid, or TXA, is a medicine that helps your body hold on to the blood clots it has already formed. Doctors call it an antifibrinolytic, which simply means it slows the breakdown of clots. It is a man-made version of lysine, an amino acid your body uses every day.
A husband and wife team in Japan developed TXA in the early 1960s. Its first jobs were heavy menstrual periods and tooth extractions. Joint replacement surgeons adopted it widely over the past two decades, and today it is standard care in my practice.
How does tranexamic acid work in knee replacement surgery?
Tranexamic acid works by stopping your body from dissolving fresh clots too early. It protects the clots you make; it does not build new ones. Here’s the picture I draw for patients across the desk.
When tissue is cut, your body forms clots on its own to seal small blood vessels. But surgery also sends in a demolition crew.
An enzyme called plasmin starts tearing those clots apart before they have finished their job. Doctors call this fibrinolysis (the breakdown of a clot’s fibrin mesh).
TXA locks that crew out. It blocks the spot where the crew needs to grab on, so the clot that’s already there just stays put. Less bleeding. Fewer transfusions.
Why does a knee replacement bleed so much?
The bone around the knee has a rich blood supply, and the cut bone surfaces ooze after surgery. Much of that loss is hidden: it seeps into the tissues over the first day or two instead of showing up on the operating table.
Before TXA, total blood loss with a knee replacement often came close to a liter, and sometimes more. That hidden loss is a big part of why patients used to feel so washed out after surgery.
How is TXA given during knee replacement?
TXA is usually given through your IV shortly before the incision, and often a second dose is placed directly into the joint before the wound is closed. Both routes are simple and add almost no time to surgery.
In my practice, most patients get the IV dose right before we start, and often I also place TXA directly in the joint before I close. Some programs use a second IV dose or tablets instead.
- IV (intravenous): given into a vein by the anesthesia team, usually before the incision.
- Topical (intra-articular): placed by the surgeon directly into the joint, so the drug works right where the bleeding happens.
Is IV or topical tranexamic acid better for knee replacement?
Both work well, and no single route has proven clearly better. Shared guidelines from the American Association of Hip and Knee Surgeons and the American Academy of Orthopaedic Surgeons found IV, topical, and oral TXA all effective, and they recommend giving it before the incision.
A randomized trial of 640 knee replacement patients at Mayo Clinic and Hospital for Special Surgery compared IV and topical TXA head to head. Transfusion rates were 0.6 percent with IV and 1.6 percent with topical TXA; both are very low.
Why do surgeons use tranexamic acid for knee replacement?
Surgeons use tranexamic acid because it reliably cuts blood loss and the need for a blood transfusion, at very low cost. Fewer transfusions means fewer of the risks that come with them.
What do tranexamic acid knee replacement studies show?
The results are remarkably consistent. A review of 14 randomized trials found that 47 percent of knee replacement patients without TXA needed a transfusion, compared with 23.5 percent of those who received it.
Newer tranexamic acid knee replacement research, with modern dosing and smarter transfusion rules, now reports rates under 2 percent.
Twenty years ago, close to half of joint replacement patients ended up getting blood. Two things changed: we stopped transfusing at the first dip in a blood count, and we started using TXA.
Why does avoiding a blood transfusion matter?
Donated blood is safe and sometimes lifesaving, but it is not risk-free. Transfusions have been linked to reactions, a higher chance of infection, and longer hospital stays.
Keeping more of your own blood also helps you feel stronger in the first week, which matters for outpatient joint replacement. And a typical TXA dose costs a fraction of one unit of donated blood.
Is tranexamic acid safe in knee replacement?
For most patients, yes. Tranexamic acid has been studied in hundreds of thousands of joint replacement patients, and serious side effects are rare. Like any medicine, it is a decision your surgical team makes for you as an individual.
Does TXA increase the risk of blood clots?
Large studies have not shown more dangerous clots in the legs or lungs with TXA. This is the question I hear most, and it makes sense: a drug that helps you stop bleeding sounds like it should cause clots.
Remember the demolition crew. TXA doesn’t start the clotting process; it only keeps existing clots from being dismantled too soon.
A study of more than 870,000 hip and knee replacement patients across 510 U.S. hospitals found no rise in clots, kidney problems, heart attacks, or strokes with TXA.
A Mayo Clinic review of more than 38,000 joint replacement patients looked at people with a past blood clot, heart attack, or stroke. Those higher-risk patients did no worse with TXA than without it. You will still get standard blood clot prevention after surgery.
What are the side effects of tranexamic acid?
Side effects at joint replacement doses are uncommon. Mild stomach upset can happen, and allergic reactions are rare. Seizures have been reported mainly with the much higher doses used in heart surgery.
Your kidneys clear TXA from the body. Most of a dose leaves through the urine within about a day, which is why kidney function matters when we plan your dose.
In the U.S., TXA’s use in joint replacement is considered off-label. That simply means the FDA label was written for other conditions, even though major orthopedic societies support its use here.
Who should not get tranexamic acid before knee replacement?
TXA is not for everyone, but it is a big help for the right patient. A few situations call for a careful conversation first, and some patients will skip it entirely.
- A recent heart stent, heart attack, or stroke
- A current, active blood clot in a leg or lung
- A history of seizures or epilepsy
- Serious kidney disease, which may require a lower dose or a different plan
- A past allergic reaction to TXA
A past history of a blood clot does not automatically rule you out. Newer research supports TXA in many of these patients, which is why I would rather talk it through than make a blanket rule.
What should I tell my surgeon before surgery?
Here’s what I tell my patients: bring a full list of your medicines, including blood thinners, and mention any heart, kidney, clotting, or seizure history. Those details shape your plan for TXA and for clot prevention afterward.
If no one has mentioned TXA before your surgery, it’s fair to ask. A good team will be glad you did.
How does Dr. Calendine use TXA for knee replacement in Middle Tennessee?
I perform more than 700 joint replacements each year, and TXA is part of my routine blood management plan for most of my knee patients. Patients from Franklin, Nashville, Columbia, and across Middle Tennessee often ask about tranexamic acid knee replacement care once they learn transfusions are now so uncommon.
TXA works best as one piece of a larger plan. Careful technique, smart choices about the tourniquet during knee replacement, and good nerve blocks for knee replacement all help you recover with less blood loss and less pain. You can learn more about the full procedure on my total knee replacement page.
Some bruising is still normal, and TXA won’t erase it. My guide to swelling after knee or hip replacement explains what to expect.
If you have questions about tranexamic acid knee replacement care, blood loss, or whether surgery is right for you, I’m happy to talk it through. Schedule a consultation with Dr. Calendine at the Bone and Joint Institute of Tennessee, 3000 Edward Curd Lane, Franklin, TN 37067, or call (615) 791-2630.
For the evidence, see the AAHKS tranexamic acid clinical practice guidelines and the 640-patient IV versus topical TXA trial.
Medical disclaimer: This article is for educational purposes only and does not replace professional medical advice. Decisions about tranexamic acid and other medicines before orthopedic surgery should be made with your own surgeon and anesthesia team, who know your full health history. Individual results vary.
References
- Abdel MP, Chalmers BP, Taunton MJ, et al. Intravenous versus topical tranexamic acid in total knee arthroplasty: both effective in a randomized clinical trial of 640 patients. J Bone Joint Surg Am. 2018;100(12):1023-1029. doi:10.2106/JBJS.17.00908
- Fillingham YA, Ramkumar DB, Jevsevar DS, et al. Tranexamic acid use in total joint arthroplasty: the clinical practice guidelines endorsed by the American Association of Hip and Knee Surgeons, American Society of Regional Anesthesia and Pain Medicine, American Academy of Orthopaedic Surgeons, Hip Society, and Knee Society. J Arthroplasty. 2018;33(10):3065-3069. doi:10.1016/j.arth.2018.08.002
- Porter SB, White LJ, Osagiede O, Robards CB, Spaulding AC. Tranexamic acid administration is not associated with an increase in complications in high-risk patients undergoing primary total knee or total hip arthroplasty: a retrospective case-control study of 38,220 patients. J Arthroplasty. 2020;35(1):45-51.e3. doi:10.1016/j.arth.2019.08.015
- Poeran J, Rasul R, Suzuki S, et al. Tranexamic acid use and postoperative outcomes in patients undergoing total hip or knee arthroplasty in the United States: retrospective analysis of effectiveness and safety. BMJ. 2014;349:g4829. doi:10.1136/bmj.g4829
- Goldstein M, Feldmann C, Wulf H, Wiesmann T. Tranexamic acid prophylaxis in hip and knee joint replacement. Dtsch Arztebl Int. 2017;114:824-830. doi:10.3238/arztebl.2017.0824
- Melvin JS, Stryker LS, Sierra RJ. Tranexamic acid in hip and knee arthroplasty. J Am Acad Orthop Surg. 2015;23(12):732-740. doi:10.5435/JAAOS-D-14-00223
- National Institute for Health and Care Excellence. Joint replacement (primary): hip, knee and shoulder. NICE guideline NG157, recommendation 1.4.1. 2020. nice.org.uk/guidance/ng157

